OSMOTICA PHARMACEUTICALS PLC(NASDAQ:OSMT) stock News

OSMT Latest News, Press Relases and Analysis

All

Press Releases

4 years ago - By: Osmotica Holdings US LLC

UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance

4 years ago - By: Benzinga

Osmotica Pharma Announces Rebranding As RVL Pharma, Issues Q4 Sales Outlook

4 years ago - By: Benzinga

Osmotica Pharmaceuticals Says Q4 Net Sales For UNPEEQ Targeted To Range From $20M-$25M

4 years ago - By: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance

4 years ago - By: Osmotica Holdings US LLC

RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022

4 years ago - By: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022

4 years ago - By: InvestorPlace - Mentions: TEDU NXGL KTTA GNCA ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

4 years ago - By: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference

4 years ago - By: Zacks Investment Research

Osmotica Pharmaceuticals (OSMT) Reports Q3 Loss, Misses Revenue Estimates

4 years ago - By: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business Update

4 years ago - By: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021

4 years ago - By: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021

4 years ago - By: Zacks Investment Research

Analysts Estimate Osmotica Pharmaceuticals (OSMT) to Report a Decline in Earnings: What to Look Out for

4 years ago - By: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public Offering

4 years ago - By: Invezz

Here’s why Osmotica Pharmaceuticals is down 35% on Thursday

4 years ago - By: Osmotica Holdings US LLC

Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 Million

4 years ago - By: Osmotica Holdings US LLC

Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public Offering

4 years ago - By: Osmotica Holdings US LLC

OSMOTICA PHARMACEUTICALS PLC (OSMT) Stock News

OSMT Latest News, Press Relases and Analysis

UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance

Osmotica Pharma Announces Rebranding As RVL Pharma, Issues Q4 Sales Outlook

Osmotica Pharmaceuticals Says Q4 Net Sales For UNPEEQ Targeted To Range From $20M-$25M

Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance

RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022

Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference

Osmotica Pharmaceuticals (OSMT) Reports Q3 Loss, Misses Revenue Estimates

Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business Update

Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021

Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021

Analysts Estimate Osmotica Pharmaceuticals (OSMT) to Report a Decline in Earnings: What to Look Out for

Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public Offering

Here’s why Osmotica Pharmaceuticals is down 35% on Thursday

Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 Million

Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public Offering

Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public Offering